BACKGROUND: In contrast to conventional laparoscopic sterilization, newer hysteroscopic approaches avoid the need for hospital admission, general anesthesia, and prolonged recovery. However, there are concerns that the feasibility, safety, and efficacy of hysteroscopic sterilization may be lower than established laparoscopic sterilization. OBJECTIVE: We sought to evaluate the outcomes of hysteroscopic sterilization compared with laparoscopic sterilization in routine clinical practice in a comparative observational cohort study. STUDY DESIGN: This study was carried out at University of Birmingham, United Kingdom, National Health Service teaching hospital, office hysteroscopy clinics, and day-case hospital unit. In all, 1085 women underwent hysteroscopic sterilization and 2412 had laparoscopic sterilization. Hysteroscopic sterilization was carried out using the tubal implant permanent birth control system in the office setting and laparoscopic sterilization using the tubal ligation system as a day-case under general anesthesia. Outcome data were collected regarding feasibility (technical completion of the sterilization procedure, satisfactory radiological confirmation at 3 monthsehysterosalpingogram or transvaginal pelvic ultrasound scan), safety events within 30 days of procedures, reoperations, and unintended pregnancies within 1 year of procedures. RESULTS: Hysteroscopic sterilization was successful in 992/1085 (91.4%; 95% confidence interval, 89.6e93.0%) at the first attempt. In comparison, bilateral tubal ligation was successfully performed in 2400/ 2412 (99.5%; 95% confidence interval, 99.2e99.8%) of patients who underwent laparoscopic sterilizations (odds ratio, 18.8; 95% confidence interval, 10.2e34.4). In all, 902/1085 (83.1%; 95% confidence interval, 80.8e85.2%) of successfully performed hysteroscopic procedures attended for radiological confirmation testing were considered satisfactory. The rate of adverse events within 30 days were similar: 2/1085 (0.2%) vs 3 (0.12%; 95% confidence interval, 0.04e0.36%). There were 3/1085 (0.3%; 95% confidence interval, 0.1e0.8%) unintended pregnancies after hysteroscopic sterilization compared with 5/2412 (0.2%; 95% confidence interval, 0.1e0.5%) laparoscopic sterilization (odds ratio, 1.3; 95% confidence interval, 0.3e5.6). Median length of follow-up for pregnancy outcome was 5 years. Hysteroscopic sterilization was associated with a higher risk of reoperation at 1 year compared to laparoscopic sterilization (odds ratio, 6.2; 95% confidence interval, 2.8e14.0) and the commonest reintervention was unilateral salpingectomy (12/22, 54.5%). CONCLUSION: Hysteroscopic sterilization has been introduced as a more convenient, office-based method of permanent fertility control. However, while the small risk of unintended pregnancy is comparable to conventional laparoscopic sterilization, women should also be counselled regarding its lower success rate in successfully completing the procedure and its higher rate of failed reoperation.
Introduction
Tubal sterilization is a widely used method of contraception, adopted by 17% of women worldwide and 12% of women in the United Kingdom. [1] [2] [3] Interval sterilization has traditionally required entry into the peritoneal cavity via laparoscopic or laparotomic routes. However, a new, hysteroscopic method of sterilization (Essure; Bayer, Leverkusen, Germany) was approved in 2002 by the US Food and Drug Administration (FDA) 4 followed by the United Kingdom National Institute for Health and Care Excellence (NICE) in 2009. 5 The Essure system involves the transcervical placement of a small, flexible nickel/titanium alloy coil containing polyethylene fibers into each fallopian tube, which induces fibrosis and tubal occlusion after 3 months. The advantage of the hysteroscopic route for tubal occlusion is the avoidance of abdominal incisions, the need for hospital admission, and the use of general or regional anesthesia. Published data highlight the convenience and economic advantages of office-based female sterilization and >750,000 Essure procedures have now been performed worldwide. 6, 7 Prospective, uncontrolled, observational data support short-and mediumterm safety, acceptability, and efficacy of hysteroscopic sterilization. Indeed, the hysteroscopic procedure has been considered safer with fewer potentially serious complications. [7] [8] [9] [10] However, this view was recently called into question by patient groups and the US FDA with reports of adverse events such as pain, bleeding, allergies, uterine trauma, and unintended pregnancies. 4, 5 The United Kingdom's Medicines and Healthcare Products Regulatory Agency concluded that tubal implant is a safe device but recommended to continue monitoring side effects following insertion. 8 While the focus of recent safety concerns concentrated on hysteroscopic procedures, there were fewer data comparing hysteroscopic and laparoscopic methods of sterilization and no randomized controlled trials. One recently published comparative cohort study from the United States reported comparable contraceptive efficacy at 1 year with unintended pregnancy rates of 1.1-1.2%. The prevalence of iatrogenic surgical complications and major medical morbidity was also similar, estimated to be <0.5%. While this study confirmed the safety and efficacy of both methods of female sterilization, it found a 10-fold higher likelihood of reoperation on the fallopian tubes after hysteroscopic sterilization amounting to 1 reoperation in every 40 hysteroscopic procedures. 6 The convenience of outpatient hysteroscopic sterilization may therefore have to be offset against the potential need for further surgical intervention to ensure tubal sterilization, remove fallopian tubes, and/or tubal implant microinserts.
To better inform clinical practice and patient decision-making regarding choice of female sterilization, we conducted a controlled cohort study to compare both methods of female sterilization to see if current comparative data pertaining to the safety, feasibility, efficacy, and need for surgical reintervention were consistent.
Materials and Methods
An observational cohort study comparing perioperative and postoperative outcomes associated with 2 contrasting methods of female sterilization was undertaken at the Birmingham Women's Hospital (BWH), a United Kingdom university teaching hospital. Data were collected over 10 years from January 2005 through November 2015 for the 2 types of female sterilization utilized; office hysteroscopic sterilization using the Essure permanent birth control system and day-case laparoscopic sterilization using the Filshie clip tubal ligation system (Femcare Ltd., Romsey, Hampshire, UK). Both procedures were conducted in accordance with the relevant instructions for use and as previously described. [4] [5] [6] Hysteroscopic procedures were conducted in an office setting with either no anesthesia or direct cervical, local anesthesia whereas all laparoscopic procedures were conducted under general anesthesia apart from 1 case performed under spinal anesthesia. Hysteroscopic sterilization procedures were performed by senior operators (consultants) trained in operative hysteroscopy (T.J.C. and J.K.G.), while laparoscopic sterilization procedures were performed by both senior operators (consultants) and obstetrics and gynecology residents (trainees).
Perioperative data pertaining to feasibility defined as technical completion of the sterilization procedure (successful bilateral microinsert placement) and satisfactory radiological confirmation at 3 months with either hysterosalpingogram (HSG) or pelvic transvaginal ultrasound scan (TVS), and safety (complications) were collected prospectively for office hysteroscopic sterilization on a specifically designed electronic database. Outcomes of confirmatory radiology at 3 months, ie, results of TVS and/or HSG required in accordance with the tubal implant permanent birth control system instructions for use and recommendations from the United Kingdom NICE 5 were also entered into the database. From 2005 through 2007, HSG was undertaken as the first-line confirmatory test. Thereafter (2007 through 2015), TVS was the first-line confirmatory test according to the protocol used at BWH (uncomplicated hysteroscopic procedures defined as taking <15 minutes, minimal pain, easy passage of devices, and 1-8 trailing device coils visible in the uterine cavity) with HSG reserved for complicated procedures or in cases where the TVS findings were equivocal. Laparoscopic sterilization procedures were retrospectively identified over the same 10-year period using BWH data coding for gynecological operative procedures. Case notes were then scrutinized to record whether procedures were successfully completed (clips correctly applied in keeping with the instructions for use to both fallopian tubes or one in the case of a prior salpingectomy) and the occurrence of intraoperative complications.
Intraoperative complications for both types of female sterilization were defined as hemorrhage >200 mL, damage to a viscus (uterus, bladder, bowel, ureter, ovary, and major blood vessel), and major medical complications (acute myocardial infarction, stroke, pulmonary embolism, perioperative shock, and respiratory complications). Postoperative complications up to 30 days following the index procedure were defined as unplanned overnight stay in hospital and iatrogenic complications (hemorrhage or hematoma, damage to an abdominal viscus, and major medical complications) requiring hospital readmission. These events were identified from BWH coding and relevant case note examination of identified cases.
The BWH operative coding system and International Classification of Diseases, Ninth Revision, Clinical Modification codes were used to identify women undergoing further surgical procedures considered to reoperations arising from the initial hysteroscopic or laparoscopic sterilization procedure, ie, as a result of failed or suboptimal procedures or complications.
Reoperations were defined as surgery to the fallopian tube (salpingectomy, Q35.4; tubal ligation/ sterilizations, Q35.2; diagnostic laparoscopy, Z30.2; clipping/blocking the remaining fallopian tube, Q36.1; hysterectomy, Q122).
Pregnancies were identified correlating the unique BWH patient identifying code with inpatient and outpatient admission codes for pregnancy and pregnancy-related care; antenatal clinic attendance; early pregnancy unit attendance (care of miscarriage and ectopic pregnancy); and termination of pregnancy. Case notes were inspected if pregnancy was identified.
In the main analyses, follow-up was limited to 1 year to avoid loss of followup because of relocation of patients. Longer-term analysis was conducted to evaluate unintended pregnancy and reoperation at any point thereafter (between 1-10 years according to the date of the index sterilization procedure).
Statistical analyses
Use of hysteroscopic sterilization and laparoscopic sterilization over time were inspected graphically and the relationship between the number of laparoscopic sterilizations and time was analyzed using Poisson regression. Baseline characteristics, successful procedures, radiological testing, and complications were compared between patients undergoing hysteroscopic and laparoscopic sterilization. Categorical variables were presented as frequencies ajog.org GYNECOLOGY Original Research and percentages. The categorical outcomes were analyzed using regression analysis and presented as unadjusted odds ratios (OR). Analysis of plots and summary statistics guided which statistical analysis was performed on continuous variables. As data were normally distributed continuous variables were presented as a mean with SD and compared using Student t test.
Results
From 2005 through 2015, 1085 women underwent hysteroscopic sterilization and 2412 had a laparoscopic sterilization. Over this 10-year study period, the use of laparoscopic sterilization remained fairly constant whereas hysteroscopic sterilization increased from 14.2% (40/280) of all female sterilization procedures in 2005 to 40.5% in 2015 (150/350) (P < .001) (Figure) . Poisson regression analysis showed a significant relationship between increasing year and an increase in the number of hysteroscopic sterilizations (P < .001). The women who underwent hysteroscopic sterilization had a significantly higher mean age (36.1 years), and higher parity (2.6) compared to the women in the laparoscopic sterilization group who had a mean age of 35.6 years and parity of 2.4 (Table) . Women undergoing hysteroscopic sterilization were nearly 3 times more likely to have had a cesarean delivery (199/1085 [18.4%] vs 160/2412 [6.6%], P < .001). They also had a significantly higher body mass index (Table) .
Hysteroscopic sterilization was successful in 992/1085 (91.4%; 95% confidence interval [CI], 89.6e93.0%) at the first attempt compared with 2400/2412 (99.5%; 95% CI, 99.2e99.8%) laparoscopic sterilizations (OR, 18.8; 95% CI, 10.2e34.4). Of the 93/1085 (8.6%) failed hysteroscopic sterilizations, 6 (6.5%) were due to device failure; 32/93 (34.4%) were difficulty in visualizing one or both tubal ostia; 15/93 (16.1%) were women unable to tolerate the procedure; and 40/ 93 (43%) were due to tubal stenosis. Initial unilateral device placement requiring a second-stage procedure to complete the hysteroscopic sterilization was required in 2/1085 (0.2%) women.
Overall, we had 12/2412 (1.5%) patients with failed laparoscopic sterilization. The reasons for failed laparoscopic procedures were mesosalpingeal tear in 1/12 (8.3%) and pelvic adhesions in 11/12 (91.7%) patients. Of the 992 completed hysteroscopic sterilization procedures, 958 (97%) attended for confirmatory radiological testing data, of which 902 (91%) patients had satisfactory confirmatory testing and so could rely on the sterilization for contraception. Where TVS was used as a first-line confirmatory radiological modality, 13.4% (63/471) required further imaging with HSG.
There were 5 adverse events reported within 30 days of the sterilization and these all occurred perioperatively or immediately postoperatively (Table) . Two perioperative complications occurred during hysteroscopic sterilization: uterine perforation during insertion of the hysteroscope and perforation of the uterine cornea while placing a tubal implant microinsert. The 3 immediate postoperative complications recorded after laparoscopic sterilization were overnight admissions: 2 because of postoperative urinary retention requiring an indwelling catheter and 1 because of abdominal pain requiring narcotic analgesia.
Women undergoing hysteroscopic sterilization were 6 times more likely to undergo a reoperation at 1 year after initial surgery (22/1085 [2%] vs 8/2412 [0.3%]; OR, 6.2; 95% CI, 2.8e14.0). Indications for reoperation were failed hysteroscopic sterilization including additional procedures to remove incorrectly placed devices (3/22, 13.6%) or pelvic pain (14/22, 68.2%). Of the failed sterilizations, 5/22 (23%) patients had a second-stage hysteroscopic procedure to achieve bilateral occlusion to the fallopian tubes, and 12/22 (54.5%) a laparoscopic sterilization (including the 1 case of device perforation). Of the 22 women who underwent reoperation at 1 year following hysteroscopic sterilization, 14 reported chronic pelvic pain without a history of pelvic pain, 9/14 (64%) had a unilateral salpingectomy due to chronic pelvic pain, 4/14 (29%) a bilateral salpingectomy, and 1/14 (7%) a laparoscopic hysterectomy because of concomitant menstrual problems.
There were 8 unintended pregnancies: 3 (0.3%; 95% CI, 0.1e0.8%) following hysteroscopic sterilization and 5 (0.2%; 95% CI, 0.1e0.5%) after laparoscopic sterilization (OR, 1.3; 95% CI, 0.3e5.6). Two of 3 pregnancies following hysteroscopic sterilization occurred despite the confirmation test (first pregnancy occurred 5 months and second pregnancy 8 months following hysteroscopic sterilization; both women terminated 
Comment
Hysteroscopic tubal implant sterilization and laparoscopic tubal ligation sterilization are comparably safe, feasible, and effective. In this series, hysteroscopic sterilization procedures were completed successfully in 83.1% of cases and the rate of unintended pregnancy was 0.3% in keeping with other observational cohorts. [11] [12] [13] However, women desiring permanent birth control need to weigh the advantages of a convenient office-based hysteroscopic procedure against the 6-fold increase in the need for further tubal surgery to complete sterilization or remove devices and/or fallopian tubes. Previous observational series have shown that while hysteroscopic sterilization is successfully completed in most women, bilateral tubal placement of Essure devices will fail in 3-10% of procedures. 11, 12 In such cases, a further attempt at hysteroscopic sterilization or alternative laparoscopic approaches should be considered. The chance of potential failure and the need for repeat procedures to complete sterilization should be discussed with women prior to undergoing office-based hysteroscopic sterilization. Women need to be aware of this small chance of requiring further tubal surgery to remove incorrectly sited devices or to treat symptoms such as pelvic pain, thought to be attributable to tubal implant device placement.
There were 8 unintended pregnancies in the cohort. In contrast to laparoscopic tubal occlusion, hysteroscopic occlusion with the tubal implant system is not immediate. Women should be advised to continue with other methods of contraception for at least 3 months until a confirmatory radiological test is completed. One of the 3 hysteroscopic pregnancies could be attributed to patient noncompliance with follow-up radiological testing. Noncompliance with radiological follow-up is well recognized with rates varying between 12.7-78% 14-16 but in our series <4% of women failed to do so. Moreover, unsatisfactory confirmation testing in compliant patients is reported to be between 4.9-5% and in keeping with our series where 3% of tests were not satisfactory. This means that 94% of the cohort of women undergoing hysteroscopic sterilization could be advised to rely on it for permanent contraception in contrast to 99% of women undergoing laparoscopic sterilization, where ajog.org GYNECOLOGY Original Research confirmatory testing is not required. Unintended pregnancy rates were comparable between methods of sterilization. The reason for all other pregnancies, which occurred >3 months of the index procedure, could not be elucidated and so may represent true method failures.
Comparison with other studies
Two recently published, US registrybased studies have compared efficacy, adverse events, and reintervention rates between hysteroscopic and laparoscopic methods of tubal occlusion, although not restricted to tubal implant and tubal ligation procedures. 17, 18 Both studies also found unintended pregnancy rates to be comparable between hysteroscopic and laparoscopic methods of sterilization albeit the reported rates of around 1% are higher than in our series (0.3%; 95% CI, 0.1e0.8%). One of these studies reported a higher tubal surgery reintervention rate following hysteroscopic sterilization consistent with our findings although the magnitude was much higher; a 10-fold increase compared with a 6-fold increase in the current study. 17 In contrast, no enhanced risk of tubal surgical reintervention arising from hysteroscopic sterilization. The US observational cohorts reflected general gynecological practice and this may explain the higher unintended pregnancy rates as our study was limited to a single center with expertise in ambulatory hysteroscopic interventions. The possible explanation for the conflicting study findings regarding the magnitude and, indeed presence, of any difference in the need for surgical reintervention directly arising from tubal sterilization is unclear and may reflect the way data were coded and recorded. It is intuitive however, that reintervention posthysteroscopic sterilization would be higher because of its higher failure rate compared with laparoscopic sterilization. It is an established part of counseling women about choices of permanent birth control that the convenience of office-based, nonincisional hysteroscopic sterilization is balanced against the increased likelihood of failure to complete the procedure. Indeed, women during the consenting process should be encouraged to consider other methods of contraception with similar efficacy 19 such as an intrauterine contraceptive device, other long-acting reversible contraceptives, laparoscopic sterilization, or male sterilization should the procedure fail. In addition, the role of laparoscopic salpingectomy as opposed to laparoscopic tubal ligation should be discussed in light of new evidence that serous adenocarcinoma, the most common ovarian cancer, may originate in the fallopian tube and removal of the tubes may mitigate against this risk.
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Strengths and limitations
The hysteroscopic sterilization data were collected prospectively from consecutive women on a bespoke electronic database whereas the laparoscopic data were collected retrospectively over the same time period. While the approach to data collection would suggest that the completeness of the hysteroscopic data is likely to be better, the inpatient operating theater coding system was rigorous with data entered prospectively for all operations, including laparoscopic sterilization, so it is unlikely that missing or inaccurate data are pervasive. Women undergoing further surgery arising from their sterilization procedure would have been missed if undertaken at another hospital. However, it is unlikely that reintervention procedures were missed given that the time scale for follow-up was restricted to 1 year, the actual reintervention rate recorded was low, and BWH was the only health care provider for hysteroscopic sterilization procedures over the study time period making representation to other regional hospitals less likely. Similarly, the risk of missing unintended pregnancies should be negligible because: (1) one would expect women to contact their health care provider; and (2) BWH would provide antenatal/gynecological care to local women so that the coding employed to identify pregnancy-related health encounters should be robust.
We did not adjust our analyses for potential confounding variables because extensive clinical and demographic data were not electronically recorded over the study period for day-case hospital procedures. Women undergoing hysteroscopic sterilization were likely to be significantly older and have a significantly higher body mass index, and were 3 times more likely to have undergone a cesarean delivery. This may suggest that when a difficult laparoscopic procedure is anticipated, women are being guided towards a hysteroscopic procedure. Our hysteroscopic bilateral device placement rates were >91.4%, which compares favorably with published rates (89-90%). 21, 22 It is unlikely that the higher prevalence of cesarean delivery would have impacted adversely on the outcomes for hysteroscopic sterilization. The only 2 observational series 17, 18 to compare female methods of sterilization also observed a higher rate of cesarean delivery but did not find this biased against hysteroscopic outcomes. One of these studies 17 also found a higher prevalence of major abdominal surgery and pelvic inflammatory disease in women undergoing hysteroscopic procedures, adding credence to the contention that the likelihood of pelvic adhesions is influencing choice of sterilization method. Again, on adjusted analysis these observations did not appear to influence the comparative results. It should also be noted that all hysteroscopic sterilizations were performed by senior surgeons with expertise in hysteroscopic surgery whereas the more established laparoscopic procedures were conducted by a wider range of surgeons with more variable experience. However, this observation is unlikely to bias against laparoscopic sterilization because it is a simple technique familiar to most gynecologists and the feasibility rate of >99% and low complication rate observed in this study is testimony to this.
Conclusion
Hysteroscopic sterilization offers women a convenient, office-based method of permanent birth control. When women choose their sterilization method, they need to understand the comparable effectiveness and safety but be aware thatewhile the chance of surgical Original Research GYNECOLOGY ajog.org reintervention for failed procedures, misplaced devices, and other clinical symptoms such as chronic pain following office-based hysteroscopic sterilization is loweit is higher than conventional laparoscopic approaches. n
